AQR Arbitrage LLC

Position in NUVL — Nuvalent, Inc.

CIK 1167456 Greenwich, CT

Position in NUVL

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$0

New position

Shares Held

601,633

first reported quarter

Ownership

0.762%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

AQR Arbitrage LLC holds $110,886,601 across 5 Biotechnology names. NUVL ranks #4 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	APGE	Apogee Therapeutics, Inc.	429,900	$57,060,627
2	TECH	BIO-TECHNE Corp	761,868	$53,825,974
3	CPRX	Catalyst Pharmaceuticals, Inc.	674,223	$0
4	NUVL	Nuvalent, Inc. This page	601,633	$0
5	VRXA	Veraxa Biotech Holding AG	658,138	$0

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	—	601,633	—	Shares	Defined	2026-08-14
No filing history on record for this holder in this stock.